FHA
GMAB icon

Flagship Harbor Advisors’s Genmab GMAB Stock Holding History

Flagship Harbor Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-176
Closed -$5.42K – 1302
2025
Q4 		$5.42K Buy
+176
New +$5.49K ﹤0.01% 1640
2020
Q3 		– Sell
-264
Closed -$8K – 2014
2020
Q2 		$8K Buy
+264
New +$7.19K ﹤0.01% 1421

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Flagship Harbor Advisors's GMAB Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Genmab (GMAB) in Q1 2026, closing a stake of 176 shares — an estimated $5.42K sold.

Flagship Harbor Advisors first reported a position in GMAB in Q2 2020 and held it in 2 quarters. The position peaked at $8K in Q2 2020. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 176 Genmab shares in Q1 2026, an estimated $5.42K.
  • Flagship Harbor Advisors first reported a position in Genmab in Q2 2020 and held it in 2 quarters.
  • Flagship Harbor Advisors's Genmab position peaked at $8K in Q2 2020.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.